Macitentan treatment retards the progression of established pulmonary arterial hypertension in an animal model.
about
Cardiovascular imaging: what have we learned from animal models?Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model.Update on novel targets and potential treatment avenues in pulmonary hypertension.Acetylcholinesterase inhibitory and antioxidant activities of novel symmetric sulfamides derived from phenethylamines.Dual ETA/ETB blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension.Effects of an endothelin receptor antagonist, Macitentan, on right ventricular substrate utilization and function in a Sugen 5416/hypoxia rat model of severe pulmonary arterial hypertension.
P2860
Macitentan treatment retards the progression of established pulmonary arterial hypertension in an animal model.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Macitentan treatment retards t ...... pertension in an animal model.
@en
type
label
Macitentan treatment retards t ...... pertension in an animal model.
@en
prefLabel
Macitentan treatment retards t ...... pertension in an animal model.
@en
P2093
P2860
P1476
Macitentan treatment retards t ...... ypertension in an animal model
@en
P2093
E J Cartwright
H Schneider
I P Temple
O Monfredi
P2860
P304
P356
10.1016/J.IJCARD.2014.09.005
P407
P577
2014-10-11T00:00:00Z